MGMichael J. Goldstein

Michael J. Goldstein

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael J. Goldstein has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Early Post‐Transplant Lactate Dehydrogenase Stratifies the Severity of Delayed Graft Function After Deceased‐Donor Kidney Transplantation

    by Samuel Sultan, Mike Fruscione, Jolie Murcko, Alexandra Erhardt, Alexey Zendel, Josue Alvarez‐Casas, Choli Hartono, Vaqar Ahmed, Fu Luan, Woojin James Chon, et al.

    Aim: Early graft dysfunction after kidney transplantation is heterogeneous, ranging from transient delayed graft function (DGF) to prolonged dialysis dependence and primary nonfunction (PNF). Biomarkers that reflect the severity of early graft injury remain limited. We evaluated whether early post‐transplant lactate dehydrogenase (LDH) is associated with the severity of graft dysfunction. Methods: We conducted a retrospective cohort study of 339 deceased‐donor kidney transplant recipients at a single centre between March 2023 and May 2024. Peak LDH during post‐operative Days 1–3 was categorized into quartiles and evaluated continuously. Outcomes included DGF, PNF, duration of dialysis dependence and longitudinal eGFR. Multivariable logistic regression adjusted for donor and recipient factors; sensitivity analyses evaluated LDH functional form, maintenance immunosuppression and additional clinical covariates. Results: DGF occurred in 20.5%, 19.5%, 28.4% and 51.2% of recipients across LDH quartiles Q1–Q4, respectively ( p < 0.001), indicating a nonlinear association with risk concentrated at higher LDH values. In adjusted categorical analysis, Q4 had substantially higher odds of DGF than Q1 (adjusted OR = 3.88; 95% CI = 1.82–8.28; p < 0.001), whereas Q2 and Q3 were not significantly different from Q1. Peak LDH remained associated with DGF when modelled continuously (adjusted OR = 1.10 per 100 U/L; 95% CI = 1.02–1.18) and after adjustment for de novo belatacept use. All six PNF events occurred in Q4. Higher LDH was also associated with lower longitudinal eGFR, particularly in Q4. Conclusion: Early post‐transplant LDH was associated with the severity of early graft dysfunction, with a nonlinear increase in DGF risk concentrated at higher LDH values. Because LDH is routinely available in the first post‐operative days but has only modest stand‐alone discrimination, it may be most useful as one component of early risk assessment. Prospective multicentre validation is needed before LDH‐based thresholds are used to direct management.

  • Daratumumab for Treatment of Acute Antibody‐Mediated Rejection in a Pediatric Kidney Transplant Recipient

    by Hailey Connolly, Ally Watson, Michael Wynd, Kenneth Lieberman, Melissa Chaung, Michael J. Goldstein, Guillermo Hidalgo, Ibrahim Batal, Marlene Amoruso, Namrata G. Jain

    Background: Daratumumab, an anti‐CD38 monoclonal antibody, has shown efficacy as a potential treatment for antibody‐mediated rejection (ABMR) following kidney transplantation in adults. Methods: We present a case demonstrating the use of daratumumab for the management of ABMR in a pediatric kidney transplant recipient. Results: The patient underwent a living‐unrelated donor renal transplant with a post‐transplant course complicated by active ABMR. The patient received a total of four daratumumab infusions with a subsequent decrease in serum creatinine, serum donor‐specific antibody levels, and donor‐derived cell‐free DNA (dd‐cfDNA), which remained low 1 year following treatment. Conclusions: Daratumumab may be a promising treatment consideration for the management of ABMR in pediatric patients following renal transplantation, though further research is needed to better understand its efficacy and side effects. DD‐cfDNA may also be a promising tool to monitor treatment response in conjunction with more traditional methods.


  • CMV‐associated collapsing focal segmental glomerulosclerosis after kidney transplant in a pediatric patient

    by Madeline F. E. Parr, Guillermo Hidalgo, Michael J. Goldstein, Ibrahim Batal, Kenneth V. Lieberman, Marlene R. Amoruso, Aryeh Z. Baer, Namrata G. Jain

    Background: Cytomegalovirus (CMV) is a significant cause of morbidity among immunocompromised patients who have undergone kidney transplantation and is known to rarely induce collapsing focal segmental glomerulosclerosis (FSGS) among adults.Methods: We present the first reported case of CMV‐induced collapsing FSGS in a pediatric patient after kidney transplant.Results: Our patient underwent a deceased donor kidney transplant due to end‐stage renal disease secondary to lupus nephritis. Approximately 4 months after transplantation, he developed signs of worsening kidney function in the setting of CMV viremia and was found to have collapsing features of FSGS on kidney transplant biopsy. He was managed with a prompt escalation of antiviral therapy along with a reduction of immunosuppression and recovered without significant complication. At follow‐up, he continued to have undetectable CMV titers, creatinine within normal limits, and no significant proteinuria.Conclusion: This report demonstrates CMV as a cause of collapsing FSGS and should be considered among pediatric transplant recipients who present with acute kidney injury, as should early assessment of APOL1 genetic status in both donor and recipient.


  • Relatives' Perceptions of Their Interactional Behavior with a Schizop/hrenic Family Member

    by Michael S. Friedmann, Michael J. Goldstein

    Relatives' (N = 77) perceptions of their recent interactional behavior with a schizophrenic family member (N = 51), as measured by an adjective checklist, were compared with outside observer ratings of the relatives' Affective Style (AS) and the patients' Coping Style (CS) during a family interaction task. Results indicated that, overall, the relatives in the present sample perceived their own interactional behavior toward the patient, as well as the patients' behavior toward them, in a way that paralleled their affective behavior as assessed by outside raters. Moreover, the relatives' rated their relationship with the patient in a fashion that was more predictive of the observed interactional behavior of both the relatives and the patients than were the outside observers' ratings of the relatives' Expressed Emotion (EE) measured either at the patients' index hospitalization (using the Camberwell Family Interview, CFI-EE) or during the post-discharge period (assessed with a brief Five-Minute Speech Sample method, FMSS-EE).


  • Thought Disorder and Communication Problems in Children With Schizophrenia Spectrum and Depressive Disorders and Their Parents

    by Martha C. Tompson, Joan R. Asarnow, Michael J. Goldstein, David J. Miklowitz

    Examined thought disorder and communication patterns in children with schizophrenia spectrum disorders (schizophrenia and schizotypal personality disorders) and their parents and in a comparison group of children with major depressive disorders and their parents. Children with schizophrenia spectrum disorders exhibited significantly more disturbed attention and thought disorder than did depressed children during a family interaction task. Although parents of children with schizophrenia spectrum disorders showed higher rates of communication deviance (CD) on the Thematic Apperception Test (TAT)-CD index than parents of depressed children, the two groups of parents were similar in the communication patterns and levels of thought disorder they exhibited during the interaction task. These findings underscore the salience of thought disorder, communication disturbance, and attentional problems in schizophrenic and schizotypal children.